California Software Co. Ltd. — Board/Management Information 2020

Aug 26, 2020

==> picture [113 x 71] intentionally omitted <==

California Software Company Limited

CIN: L72300TN1992PLC022135

Registered Office: 2[nd] Floor, Unit 9, STPI Building, 5 Rajiv Gandhi Salai, Taramani, Chennai 600 113, India Phone +91 044 3910 3620

Email: investor@calsoftgroup.com www.calsoftgroup.com/www.calsof.com

August 26, 2020

To

Exchange Plaza, 5thFloor, Plot No. C/1, G Block, Bandra-Kurla Complex Bandra (East), Mumbai - 400 051

BSE LIMITED

Security Code - 532386

Phiroze Jeejeebhoy Towers Dalal Street Mumbai-400001

---

Dear Sir/Madam,

Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015 – Appointment of Director

We hereby inform you that the Board of Directors, at their meeting held today viz., 26.08.2020 based on the recommendation of the Nomination and Remuneration Committee has appointed Dr.Chandan RS (DIN: 08849851) as an Additional Director in the category of Non-Executive Independent, for a term of 5 years with effect from 26th August, 2020 for a tenure of 5 (five) years subject to approval of members of the Company.

As per the prescribed format under SEBI circular, the brief details regarding Dr.Chandan RS is attached in Annexure A .

Further, it is confirmed that Dr.Chandan RS is not debarred from holding the office of director by virtue of any SEBI order or any other such authority.

This is for your information and record.

Thanking you,

Yours truly

For California Software Company Limited

==> picture [79 x 82] intentionally omitted <==

Vasudevan Mahalingam Chief Executive Officer & Managing Director

==> picture [113 x 71] intentionally omitted <==

California Software Company Limited

CIN: L72300TN1992PLC022135

Registered Office: 2[nd] Floor, Unit 9, STPI Building, 5 Rajiv Gandhi Salai, Taramani, Chennai 600 113, India Phone +91 044 3910 3620 Email: investor@calsoftgroup.com www.calsoftgroup.com/www.calsof.com

Annexure A

Details under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read along with SEBI Circular CIR/CFD/CMD/4/2015 dated September 09, 2015

S.No.	Particulars	Particulars	Details
1.	Reason for change viz: appointment, resignation,removal,death or otherwise		Appointment
2.	Date of Appointment/ appointment	~~Cessation~~ & term of	26thAugust 2020. Appointed as an Additional Director in the category of Non-Executive Independent, for a term of 5 years with effect from 26th August, 2020 for a tenure of 5 (five) years subject to approval of members of the Company.
3.	Brief Profile		Doctorate in Pharmaceutical Analysis from Dr. M.G.R. Educational and Research Institute University, Chennai and Post graduate in Pharmacy with specialization in Pharmaceutical Analysis with more than 19 years of experience in Education & Training, Clinical (BA/BE) Study Coordination, Clinical Research and Drug Testing Laboratory. Assistant Professor in Pharmaceutical Chemistry Department and Quality Manager in JSS Drug Testing Laboratory with JSS College of Pharmacy, Mysore, India. Experience in various functions in a CRO viz., protocol development, preparation of SOPs, execution of audits, review of study plans and reports.
4.	Disclosure of relationships between directors		Dr.Chandan RS is not related to any of the Directors of the Company.
	Personal Details of Appointee
5.	Name		Dr.Chandan RS
	DIN		08849851
	Date of Birth		22-08-1973
	Educational Qualifications		Master of Pharmacy and Doctorate in Pharmaceutical Analysis.